These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 19353221)

  • 1. Predictors of progression of cognitive decline in Alzheimer's disease: the role of vascular and sociodemographic factors.
    Musicco M; Palmer K; Salamone G; Lupo F; Perri R; Mosti S; Spalletta G; di Iulio F; Pettenati C; Cravello L; Caltagirone C
    J Neurol; 2009 Aug; 256(8):1288-95. PubMed ID: 19353221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive deterioration in Alzheimer's disease: is the early course predictive of the later stages?
    Capitani E; Cazzaniga R; Francescani A; Spinnler H
    Neurol Sci; 2004 Oct; 25(4):198-204. PubMed ID: 15549505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can the treatment of vascular risk factors slow cognitive decline in Alzheimer's disease patients?
    Richard F; Pasquier F
    J Alzheimers Dis; 2012; 32(3):765-72. PubMed ID: 22886010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Vascular Risk Factors on the Progression of Mild Alzheimer's Disease and Lewy Body Dementia.
    Bergland AK; Dalen I; Larsen AI; Aarsland D; Soennesyn H
    J Alzheimers Dis; 2017; 56(2):575-584. PubMed ID: 28035932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of vascular lesions on cognition in Alzheimer's disease: a community-based study.
    Riekse RG; Leverenz JB; McCormick W; Bowen JD; Teri L; Nochlin D; Simpson K; Eugenio C; Larson EB; Tsuang D
    J Am Geriatr Soc; 2004 Sep; 52(9):1442-8. PubMed ID: 15341544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From mild cognitive impairment to Alzheimer's disease - influence of homocysteine, vitamin B12 and folate on cognition over time: results from one-year follow-up.
    Siuda J; Gorzkowska A; Patalong-Ogiewa M; Krzystanek E; Czech E; Wiechuła B; Garczorz W; Danch A; Jasińska-Myga B; Opala G
    Neurol Neurochir Pol; 2009; 43(4):321-9. PubMed ID: 19742390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular risk factors and progression in Alzheimer's disease.
    Sakurai H; Hanyu H; Sato T; Kanetaka H; Shimizu S; Hirao K; Kikukawa M; Iwamoto T
    Geriatr Gerontol Int; 2011 Apr; 11(2):211-4. PubMed ID: 21143566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrovascular disease in the elderly: lipoprotein metabolism and cognitive decline.
    Panza F; Solfrizzi V; Colacicco AM; D'Introno A; Capurso C; Palasciano R; Todarello O; Capurso S; Pellicani V; Capurso A
    Aging Clin Exp Res; 2006 Apr; 18(2):144-8. PubMed ID: 16702784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of blood pressure changes on Alzheimer's disease.
    Feldstein CA
    Neuroepidemiology; 2010; 35(3):202-12. PubMed ID: 20664211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical predictors of cognitive decline in patients with mild cognitive impairment: the Chongqing aging study.
    Li L; Wang Y; Yan J; Chen Y; Zhou R; Yi X; Shi Q; Zhou H;
    J Neurol; 2012 Jul; 259(7):1303-11. PubMed ID: 22186849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease.
    Sanz C; Andrieu S; Sinclair A; Hanaire H; Vellas B;
    Neurology; 2009 Oct; 73(17):1359-66. PubMed ID: 19858457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting the age of onset and rate of progression of Alzheimer's disease.
    Bowler JV; Munoz DG; Merskey H; Hachinski V
    J Neurol Neurosurg Psychiatry; 1998 Aug; 65(2):184-90. PubMed ID: 9703168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of cerebral emboli with accelerated cognitive deterioration in Alzheimer's disease and vascular dementia.
    Purandare N; Burns A; Morris J; Perry EP; Wren J; McCollum C
    Am J Psychiatry; 2012 Mar; 169(3):300-8. PubMed ID: 22193532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Progression of Alzheimer's Disease: Are Fast Decliners Really Fast? A Four-Year Follow-Up.
    Barocco F; Spallazzi M; Concari L; Gardini S; Pelosi A; Caffarra P
    J Alzheimers Dis; 2017; 57(3):775-786. PubMed ID: 28304306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An abnormal "one-leg balance" test predicts cognitive decline during Alzheimer's disease.
    Rolland Y; Abellan van Kan G; Nourhashemi F; Andrieu S; Cantet C; Guyonnet-Gillette S; Vellas B
    J Alzheimers Dis; 2009; 16(3):525-31. PubMed ID: 19276547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease.
    Li J; Wang YJ; Zhang M; Xu ZQ; Gao CY; Fang CQ; Yan JC; Zhou HD;
    Neurology; 2011 Apr; 76(17):1485-91. PubMed ID: 21490316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
    Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
    Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive decline and survival in Alzheimer's disease according to education level.
    Bruandet A; Richard F; Bombois S; Maurage CA; Masse I; Amouyel P; Pasquier F
    Dement Geriatr Cogn Disord; 2008; 25(1):74-80. PubMed ID: 18042993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive correlates of α4β2 nicotinic acetylcholine receptors in mild Alzheimer's dementia.
    Sabri O; Meyer PM; Gräf S; Hesse S; Wilke S; Becker GA; Rullmann M; Patt M; Luthardt J; Wagenknecht G; Hoepping A; Smits R; Franke A; Sattler B; Tiepolt S; Fischer S; Deuther-Conrad W; Hegerl U; Barthel H; Schönknecht P; Brust P
    Brain; 2018 Jun; 141(6):1840-1854. PubMed ID: 29672680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up.
    Devanand DP; Michaels-Marston KS; Liu X; Pelton GH; Padilla M; Marder K; Bell K; Stern Y; Mayeux R
    Am J Psychiatry; 2000 Sep; 157(9):1399-405. PubMed ID: 10964854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.